Project 1: To investigate the neuroanatoimical correlates of attentional processing bias in nicotine addicts, using fMRI.Project 2: To examine whether attentional biases are dependent on dopaminergic transmission in the mesolimbic system using…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
Verslaving
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study parameter is the brain activity in multiple brain regions in
reaction to the attention tasks, accompanied by behavioural responses to the
tasks (reaction times). The end of this study will be reached when eighty
participants are included and tested successfully.
Secondary outcome
Not applicable
Background summary
Addictive behaviours, such as smoking, are associated with biases in the
processing of drug-related stimuli. These processing biases are hypothesized to
have a causal effect on substance use and relapse in addiction. However, little
is known about the neural mechanisms behind these biases. Current studies
provide preliminary indications that addiction-related stimuli yield
differential neural activation in addicts as compared to other stimuli,
suggesting enhanced processing of these stimuli. However, more detailed
knowledge about the neurobiology of these biases is needed in order to design
better treatments for this chronic and invalidating condition. We will
investigate the neurobiology of attentional biases in two complementary
projects.
Study objective
Project 1: To investigate the neuroanatoimical correlates of attentional
processing bias in nicotine addicts, using fMRI.
Project 2: To examine whether attentional biases are dependent on dopaminergic
transmission in the mesolimbic system using pharmaco-fMRI with a dopamine
challenge.
Study design
In the first project, participants will perform two attention tasks in the fMRI
scanner to examine the neural correlates of attentional bias. In the second
project a double-blind placebo controlled cross-over design will be used. In
both sessions participants will get either a single dose 2mg haloperidol of
placebo and perform the the attention tasks in the fMRI scanner. In both
projects 20 smokers will be compared with 20 non-smokers. Participants need to
abstain from alcohol use for 24 hours before scanning and 3 hours from smoking.
Study burden and risks
fMRI is a save and non-invasive method for measuring brain activity. Since
participants have to lie still in the scanner and are exposed to scanner noise,
effort will be made to make it as comfortable as possible. Previous studies
have shown that a challenge with a single dose 2mg haloperdiol can be used
safely without complications in these kind of study designs.
Postbus 1738
3000 DR Rotterdam
NL
Postbus 1738
3000 DR Rotterdam
NL
Listed location countries
Age
Inclusion criteria
Signed informed consent
Age between 18 and 55 years
Smoking at least 15 cigarettes a day for smokers / not smoked more than 3 cigarettes lifetime for non smokers
Right handedness
Exclusion criteria
fMRI contraindications
Indications of psychopathology
Use of psychoactive medication
Regular use of drugs of abuse other than nicotine
Claustrophobia
Pregnancy
For project two: contra-indication for taking a single low dose of haloperidol
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL22250.078.08 |